MedTrace Logo

Effectiveness and Safety of Topical Hyaluronic Acid of Different Molecular Weights in Xerotic Skin Treatment

NCT06178367 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2024-04-30

No results posted yet for this study

Summary

The goal of this clinical trial is to compare 0,1% topical low molecular weight (7 kDa) hyaluronic acid with 0,1% high molecular weight (1.800 kDa) hyaluronic acid as therapy of xerotic skin in elderly

Conditions

  • Xerosis Cutis

Interventions

DRUG

Low molecular weight hyaluronic acid

Topical 0,1% low molecular weight (7 kDa) hyaluronic acid in vehicle

DRUG

High molecular weight hyaluronic acid

Topical 0,1% high molecular weight (1.800 kDa) hyaluronic acid in vehicle

DRUG

Vehicle

Vehicle ingredients including aqua, paraffinum liquidum, glycerin, petrolatum, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, arachidyl alcohol, squalane, behenyl alcohol, phenoxyethanol, arachidyl glucoside, allantoin, chlorphenesin, and disodium EDTA

Sponsors & Collaborators

  • Indonesia University

    lead OTHER

Principal Investigators

  • Parikesit Muhammad, MD · Faculty of Medicine, University of Indonesia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-26
Primary Completion
2023-09-30
Completion
2023-09-30

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06178367 on ClinicalTrials.gov